Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity (2022)
Attributed to:
LIMK1 inhibitors - A novel, disease-modifying approach for the treatment of fragile X syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.2c00751
PubMed Identifier: 36205722
Publication URI: http://europepmc.org/abstract/MED/36205722
Type: Journal Article/Review
Parent Publication: Journal of Medicinal Chemistry
Issue: 20
ISSN: 0022-2623